Cargando…

P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)

Detalles Bibliográficos
Autores principales: Kempter, Tamara, Richter-Pechanska, Paulina, Michel, Katarzyna, Rausch, Tobias, Erarslan-Uysal, Büşra, Eckert, Cornelia, Zimmermann, Martin, Stanulla, Martin, Schrappe, Martin, Cario, Gunnar, Kirschner-Schwabe, Renate, Koehrer, Stefan, Korbel, Jan, Kunz, Joachim, Kulozik, Andreas E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428478/
http://dx.doi.org/10.1097/01.HS9.0000968244.94930.74
_version_ 1785090479741730816
author Kempter, Tamara
Richter-Pechanska, Paulina
Michel, Katarzyna
Rausch, Tobias
Erarslan-Uysal, Büşra
Eckert, Cornelia
Zimmermann, Martin
Stanulla, Martin
Schrappe, Martin
Cario, Gunnar
Kirschner-Schwabe, Renate
Koehrer, Stefan
Korbel, Jan
Kunz, Joachim
Kulozik, Andreas E
author_facet Kempter, Tamara
Richter-Pechanska, Paulina
Michel, Katarzyna
Rausch, Tobias
Erarslan-Uysal, Büşra
Eckert, Cornelia
Zimmermann, Martin
Stanulla, Martin
Schrappe, Martin
Cario, Gunnar
Kirschner-Schwabe, Renate
Koehrer, Stefan
Korbel, Jan
Kunz, Joachim
Kulozik, Andreas E
author_sort Kempter, Tamara
collection PubMed
description
format Online
Article
Text
id pubmed-10428478
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284782023-08-17 P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) Kempter, Tamara Richter-Pechanska, Paulina Michel, Katarzyna Rausch, Tobias Erarslan-Uysal, Büşra Eckert, Cornelia Zimmermann, Martin Stanulla, Martin Schrappe, Martin Cario, Gunnar Kirschner-Schwabe, Renate Koehrer, Stefan Korbel, Jan Kunz, Joachim Kulozik, Andreas E Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428478/ http://dx.doi.org/10.1097/01.HS9.0000968244.94930.74 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Kempter, Tamara
Richter-Pechanska, Paulina
Michel, Katarzyna
Rausch, Tobias
Erarslan-Uysal, Büşra
Eckert, Cornelia
Zimmermann, Martin
Stanulla, Martin
Schrappe, Martin
Cario, Gunnar
Kirschner-Schwabe, Renate
Koehrer, Stefan
Korbel, Jan
Kunz, Joachim
Kulozik, Andreas E
P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
title P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
title_full P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
title_fullStr P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
title_full_unstemmed P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
title_short P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
title_sort p333: subclonal and clonal variants in tp53 and kras combined with poor treatment response identify a subgroup of ultra-high-risk patients of pediatric t-lymphoblastic leukemia (t-all)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428478/
http://dx.doi.org/10.1097/01.HS9.0000968244.94930.74
work_keys_str_mv AT kemptertamara p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT richterpechanskapaulina p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT michelkatarzyna p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT rauschtobias p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT erarslanuysalbusra p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT eckertcornelia p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT zimmermannmartin p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT stanullamartin p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT schrappemartin p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT cariogunnar p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT kirschnerschwaberenate p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT koehrerstefan p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT korbeljan p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT kunzjoachim p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall
AT kulozikandrease p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall